Management & Directors

Amy Lance: Interim CEO, Chairman of the Board of Directors
Ms. Amy Lance, age 50, joins the Board as Chairman of the Board and will also serve as Interim CEO. Ms. Lance has extensive business experience and is a leading figure in the not-for-profit community, as well as real estate related activities in the Southeastern U.S. Ms. Lance graduated from The University of Georgia with a BA in Business Management in 1988.

Mack Leath: Director
Mr. Mack Leath, age 59, was appointed to the Board of Directors, and as Secretary of the Company. As well Mr. Leath will become the Interim President of the Corporation. He is an experienced business executive with an emphasis on sales and marketing as well as start-up oriented financing transactions. He will be responsible for all aspects of the day to day operations of the Company. Mr. Leath graduated from North Carolina State University with a B.S. in Business Administration; 1986.

Dr. Jordan Balencic, D.O.: Director

Also joining the Board is Dr. Jordan Balencic, D.O. age 30, who is a physician of internal medicine and an entrepreneur and founder of businesses in the social marketing, telemedicine and web services areas. He has graduated from Lake Erie College of Osteopathic Medicine in 2013 and has a B.S. from Gannon University in Biology. He belongs to numerous professional organizations and is involved with the Veterans Administration as a primary care physician.

On September 28, 2016, the Board agreed to create a non-executive, non-governance Advisory Board and appoint to it up to eight (8) individuals who have technical skills in the healthcare and pharmacy area. Their compensation shall be the issuance of 100,000 shares of restricted common stock for the next 12 months of services.

The initial appointments shall be:

  1. Dr. James G. McMurray, MD age 75, is an early investor in the Company and a 40+ year practicing Urologist located in Huntsville, AL, where he is Medical Director and Principal Investigator of Urology for the Medical Affiliated Research Center ( , an independent clinical research entity funded by pharmaceutical companies. He is an AUA Board certified Urologist who has lead numerous trials associated with urology.
  2. Phillip Giordano, age 57, is the owner of a compounding pharmacy in Boca Raton, Florida which specializes in both veterinary medicine as well as specialized human medications. He is a licensed pharmacist, and has advised the Company since the formation of Newco4pharmacy, LLC, which was acquired by the Company in 2015. Previously as Director of Pharmacy Services in Pompano Beach, Florida, he was responsible for sales and distribution of all internet related prescription sales in 16 states, and internationally.

The members of this Board shall not be deemed to be officers or directors of the Company as defined in Section 16 of the Securities Act, and shall have no operating role in the Company.